Aug 4, 2025 10:22AM
Aug 4, 2025 10:22AM
Jul 30, 2025 04:40PM
May 20, 2025 05:20AM
May 19, 2025 08:01PM
May 14, 2025 04:20PM
May 14, 2025 08:44AM Form F-1 MAINZ BIOMED N.V.
Dec 11, 2024 08:01AM
Dec 9, 2024 05:14PM
Dec 9, 2024 09:17AM
Nov 5, 2024 08:01AM
Sep 20, 2022 05:54AM
Sep 20, 2022 03:01AM
Sep 20, 2022 03:01AM Mainz Biomed Appoints Dr. Douglas Rex to its Medical Advisory Board
Sep 7, 2022 03:01AM
Sep 7, 2022 03:01AM
Sep 1, 2022 03:01AM
Sep 1, 2022 03:01AM
Aug 23, 2022 03:01AM
Aug 23, 2022 03:01AM
Aug 3, 2022 05:48AM Mainz Biomed (MYNZ) Appoints Frank Krieg-Schneider as VP of Development
Aug 3, 2022 03:01AM
Aug 3, 2022 03:01AM
Jul 19, 2022 03:01AM
Jul 19, 2022 03:01AM
Jul 12, 2022 03:01AM
Jul 12, 2022 03:01AM
Jul 5, 2022 05:57AM Mainz Biomed (MYNZ) Issues H1 2022 Corporate Update
Jul 5, 2022 03:01AM
Jul 5, 2022 03:01AM
Jun 28, 2022 03:01AM
Jun 28, 2022 03:01AM
Jun 14, 2022 03:01AM
Jun 14, 2022 03:01AM
Jun 1, 2022 05:55AM Mainz Biomed (MYNZ) Announces Completion of Conformity Assessment to IVDR Achieving New Level of EU Regulatory Compliance
Jun 1, 2022 03:01AM
Jun 1, 2022 03:01AM
May 17, 2022 03:01AM
May 17, 2022 03:01AM
May 5, 2022 05:42AM
May 5, 2022 03:01AM
May 5, 2022 03:01AM Mainz Biomed Provides Product Development Update on PancAlert
Apr 26, 2022 05:38AM
Apr 26, 2022 03:01AM
Apr 26, 2022 03:01AM
Apr 12, 2022 05:39AM
Apr 12, 2022 03:01AM
Apr 12, 2022 03:01AM
Mar 31, 2022 03:01AM Mainz Biomed Completes Successful Pre-Submission Process with the U.S FDA for ColoAlert’s Pivotal Clinical Trial
Mar 31, 2022 03:01AM

14,665 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All